1. Home
  2. RNTX vs RYOJ Comparison

RNTX vs RYOJ Comparison

Compare RNTX & RYOJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.47

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

RYOJ

rYojbaba Co. Ltd.

N/A

Current Price

$3.87

Market Cap

42.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
RNTX
RYOJ
Founded
2001
2015
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
42.8M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
RNTX
RYOJ
Price
$1.47
$3.87
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
234.4K
56.4K
Earning Date
11-14-2025
12-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.91
EPS
N/A
0.13
Revenue
N/A
$11,576,848.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$29.95
Revenue Growth
N/A
5.60
52 Week Low
$1.04
$1.81
52 Week High
$3.50
$11.43

Technical Indicators

Market Signals
Indicator
RNTX
RYOJ
Relative Strength Index (RSI) 53.37 N/A
Support Level $1.34 N/A
Resistance Level $1.58 N/A
Average True Range (ATR) 0.10 0.00
MACD 0.01 0.00
Stochastic Oscillator 62.50 0.00

Price Performance

Historical Comparison
RNTX
RYOJ

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

About RYOJ rYojbaba Co. Ltd.

rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.

Share on Social Networks: